Share Price

Sun Pharma shares drop over 3% on disappointing earnings in Jul-Sep quarter

Sun Pharma's consolidated total revenue from operations stood at Rs 6,650.34 crore

Yes Bank shares tank over 7% as bad loans surge to Rs 2,720 cr in Jul-Sep quarter

Yes Bank' bad loan situation deteriorated as the gross NPAs grew to Rs 2,720.34 cr (1.82%) during the second quarter of 2017-18 from Rs 916.68 cr (0.83%) in the corresponding period last year

Bharti Airtel jumps 8% on Tata Teleservices mobile unit acquisition

Bharti Airtel is set to take over Tata group's money-losing mobile business from 1 November

Infosys fixes 1 November as record date for Rs 13,000-crore share buyback, stock up 1.43%

The share buyback, which will be the first in the company's 36-year long history, will see Infosys buying back over 11.30 crore shares at Rs 1,150 apiece

Natco Pharma zooms 20% as partner's injection gets USFDA nod

US Food and Drug Administration granted approval to the Natco Pharma's marketing partner Mylan's injection used for treatment of relapsing forms of multiple sclerosis

Reliance Communications stock tanks 9% after Aircel merger deal falls through

Reliance Communications, on 1 October, had called off merger talks with Aircel, citing "legal and regulatory" delays

Fortis Healthcare soars 8% after Rekha Jhunjhunwala buys stake

Rekha Jhunjhunwala picked up 45 lakh shares of the company for an estimated Rs 60 crore through an open market transaction

HCL Infosystems up 18% on plans to distribute Apple products in India

In a regulatory filing on Monday, HCL Infosystems said it has signed an agreement for "distribution of iPhone and other Apple products" with Apple India.

Infosys shares extend slide, down 4.55% to Rs 881.15 as wary investors sell stock

The scrip of Infosys continued to reel under pressure for the second consecutive session on Monday, falling 4.5 percent, despite the company's share buyback announcement

Infosys shares extend decline as brokerages downgrade stock over fears of uncertainty

Nomura downgraded the stock to "reduce", saying the uncertainty over Infosys' management could hamper long-term growth